- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
China Resources Pharmaceutical Group Ltd (3320)
China Resources Pharmaceutical Group Ltd stock price live, this page displays HK 3320 stock exchange data. View the 3320 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the China Resources Pharmaceutical Group Ltd real time stock price chart below.
What Is the China Resources Pharmaceutical Group Ltd Stock Price Today?
The China Resources Pharmaceutical Group Ltd stock price today is 4.50.
What Is the Stock Symbol for China Resources Pharmaceutical Group Ltd?
The stock symbol for China Resources Pharmaceutical Group Ltd is "3320."
What Stock Exchange Does China Resources Pharmaceutical Group Ltd Trade On?
China Resources Pharmaceutical Group Ltd is listed and trades on the Hong Kong stock exchange.
Is China Resources Pharmaceutical Group Ltd a Good Stock to Buy?
Determining whether China Resources Pharmaceutical Group Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 3320 quote. (ISIN: HK0000311099)
What Is the China Resources Pharmaceutical Group Ltd Stock Price Today?
The China Resources Pharmaceutical Group Ltd stock price today is 4.50.
What Is the Stock Symbol for China Resources Pharmaceutical Group Ltd?
The stock symbol for China Resources Pharmaceutical Group Ltd is "3320."
What Stock Exchange Does China Resources Pharmaceutical Group Ltd Trade On?
China Resources Pharmaceutical Group Ltd is listed and trades on the Hong Kong stock exchange.
Is China Resources Pharmaceutical Group Ltd a Good Stock to Buy?
Determining whether China Resources Pharmaceutical Group Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 3320 quote. (ISIN: HK0000311099)
Hong Kong
Currency in HKD
4.50
+0.06(+1.35%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.37
4.52
52 wk Range
4.22
6.53
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.374.52
52 wk Range
4.226.53
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.91%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.91%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
3320 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
6.79
Upside
+50.82%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock price often moves in the opposite direction of the market
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Analyst Ratings
10 Buy
1 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 6.79
(+50.82% Upside)
Earnings
Latest Release
Sep 26, 2025
EPS / Forecast
0.33 / 0.55
Revenue / Forecast
131.87B / --
Compare 3320 to Peers and Sector
Metrics to compare | 3320 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship3320PeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | 16.6x | −0.4x | |
PEG Ratio | 0.00 | −0.34 | 0.00 | |
Price/Book | 0.0x | 1.4x | 2.6x | |
Price / LTM Sales | 0.0x | 2.1x | 3.0x | |
Upside (Analyst Target) | 0.0% | 41.6% | 51.5% | |
Fair Value Upside | Unlock | 22.2% | 8.8% | Unlock |
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular, metabolism, intravenous infusion, and cerebrovascular diseases, alimentary tract, endocrine diseases, respiratory diseases, orthopedics, nephrology, rheumatology and immunology, medical nutrition, pediatrics, genitourinary system, dermatological diseases, blood products, therapeutic infusions, antitumor drugs, medicine for cough and cold, anti-infection drugs, and psychoneurosis. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical/medical device manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operating retail pharmacies under the Teck Soon Hong brands. It distributes its products under the 999, Dong-E-E-Jiao, Double Crane, Zizhu, Jiangzhong, Boya, Kun Zhong Yao, and Tasly to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited operates as a subsidiary of CRH (Pharmaceutical) Limited.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the China Resources Pharma (3320) Stock Price Today?
The China Resources Pharma stock price today is 4.50 HKD.
What Stock Exchange Does China Resources Pharma Trade On?
China Resources Pharma is listed and trades on the Hong Kong Stock Exchange.
What Is the Stock Symbol for China Resources Pharma?
The stock symbol for China Resources Pharma is "3320."
Does China Resources Pharma Pay Dividends? What’s The Current Dividend Yield?
The China Resources Pharma dividend yield is 4.91%.
What Is the China Resources Pharma Market Cap?
As of today, China Resources Pharma market cap is 28.27B HKD.
What Is China Resources Pharma's Earnings Per Share (TTM)?
The China Resources Pharma EPS (TTM) is 0.64.
From a Technical Analysis Perspective, Is 3320 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has China Resources Pharma Stock Split?
China Resources Pharma has split 0 times.
How Many Employees Does China Resources Pharma Have?
China Resources Pharma has 85600 employees.
What is the current trading status of China Resources Pharma (3320)?
As of Jul 11, 2026, China Resources Pharma (3320) is trading at a price of 4.50 HKD, with a previous close of 4.44 HKD. The stock has fluctuated within a day range of 4.37 HKD to 4.52 HKD, while its 52-week range spans from 4.22 HKD to 6.53 HKD.
What Is China Resources Pharma (3320) Price Target According to Analysts?
The average 12-month price target for China Resources Pharma is 6.79 HKD, with a high estimate of 7.52 HKD and a low estimate of 5.9 HKD. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +50.82% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.